An image
Fatty Liver Disease:
A Growing Epidemic
An image
NASH is on track to be the leading cause of liver transplants.

Rimidi offers a comprehensive, progressive model of care to screen at-risk populations, risk stratify patients, and help clinicians guide them to the right level of care. 
Rimidi's Solution for Fatty Liver

Within your EHR workflow, Rimidi supports the complexity of diagnosing NAFLD and NASH. 
Step 1: Identify at-risk patients
An image
Whether a patient engages your health system through primary care, bariatrics, endocrinology or hepatology, Rimidi’s platform helps aggregate patient data directly through your EHR and identify the population at risk of NAFLD and NASH.
Step 2: Intervene with guideline-based management
An image
Once a patient is identified as at-risk, Rimidi provides a progressive care model, guiding physicians to the right level of intervention— whether that’s a specialist referral, bloodwork, or a Fibroscan.
© 2019 Rimidi Diabetes Inc. All Rights Reserved.